Abu Dhabi Opens Health 'Living Lab'
Analysis based on 7 articles · First reported May 07, 2026 · Last updated May 07, 2026
The initiative by MGX to become a global test-bed for AI-enabled health innovation is expected to attract significant investment and foster growth in the healthcare and biotechnology sectors. This could lead to new opportunities for companies involved in drug discovery, AI development, and health technology, potentially boosting their stock prices and market valuations.
H.E. Mansoor Ibrahim Al Mansoori, Chairman of the United Arab Emirates — Department of Health – Abu Dhabi, announced at the Milken Institute Global Conference that MGX is opening its 'living lab' to global partners, investors, and innovators. The goal is to accelerate the development and scaling of next-generation health solutions, particularly those enabled by AI. MGX aims to be a global test-bed for real-world health innovation, leveraging its integrated, intelligent health infrastructure and comprehensive data. The initiative emphasizes a shift towards proactive, prevention-first healthcare, utilizing AI Agents within the Unified Medical Operations Command Centre for real-time incident detection and faster emergency response. This long-term plan is part of MGX's economic diversification strategy, focusing on strategic investment in technology, infrastructure, and people.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard